Alpha 2.0
Login Register
» Articles » PMID: 27854534

Further Decline of Trans Fatty Acids Levels Among US Adults Between 1999-2000 and 2009-2010

Overview
Journal Am J Public Health
Specialty Public Health
Date 2016 Nov 18
PMID 27854534
Citations 5
Authors
Brandon J Restrepo
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate differences in levels of plasma trans fatty acids (TFAs) and a broad set of other markers for cardiovascular disease (CVD) risk in the US adult population between 1999-2000 and 2009-2010.

Methods: Using a nationally representative sample of US adults aged 20 years and older from the 1999-2000 and 2009-2010 waves of the National Health and Nutrition Examination Survey, regression models were estimated to compare levels of TFAs and other markers for CVD risk over time.

Results: Significant declines in levels of plasma TFAs and improvements in a variety of other markers for CVD risk were observed in the US adult population.

Conclusions: Between the 2 time points, 1999-2000 and 2009-2010, there were substantial decreases in TFA levels and improvements in several other important cardiovascular health indicators in US adults.

Citing Articles

Age-Related Factors Associated With The Risk of Hip Fracture.

Buzkova P, Cauley J, Fink H, Robbins J, Mukamal K, Barzilay J Endocr Pract. 2023; 29(6):478-483.

PMID: 36889582 PMC: 10258141. DOI: 10.1016/j.eprac.2023.03.001.

Presence of -Fatty Acids Containing Ingredients in Pre-Packaged Foods and the Availability of Reported -Fat Levels in Kenya and Nigeria.

Huang L, Ojo A, Kimiywe J, Kibet A, Ale B, Okoro C Nutrients. 2023; 15(3).

PMID: 36771466 PMC: 9919578. DOI: 10.3390/nu15030761.

Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.

Huang N, Buzkova P, Matthan N, Djousse L, Hirsch C, Kizer J J Am Heart Assoc. 2021; 10(6):e019135.

PMID: 33682438 PMC: 8174223. DOI: 10.1161/JAHA.120.019135.

Intake of -fats among US youth declined from 1999-2000 to 2009-2010.

Restrepo B Public Health Nutr. 2020; 23(6):1103-1107.

PMID: 31918772 PMC: 10200375. DOI: 10.1017/S1368980019003367.

Plasma trans-fatty acids levels and mortality: a cohort study based on 1999-2000 National Health and Nutrition Examination Survey (NHANES).

Li H, Zhang Q, Song J, Wang A, Zou Y, Ding L Lipids Health Dis. 2017; 16(1):176.

PMID: 28915883 PMC: 5603045. DOI: 10.1186/s12944-017-0567-6.

References
1.
Mozaffarian D, Katan M, Ascherio A, Stampfer M, Willett W . Trans fatty acids and cardiovascular disease. N Engl J Med. 2006; 354(15):1601-13. DOI: 10.1056/NEJMra054035. View
2.
Mozaffarian D, Aro A, Willett W . Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009; 63 Suppl 2:S5-21. DOI: 10.1038/sj.ejcn.1602973. View
3.
Heidenreich P, Trogdon J, Khavjou O, Butler J, Dracup K, Ezekowitz M . Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123(8):933-44. DOI: 10.1161/CIR.0b013e31820a55f5. View
4.
Vesper H, Kuiper H, Mirel L, Johnson C, Pirkle J . Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA. 2012; 307(6):562-3. PMC: 5813280. DOI: 10.1001/jama.2012.112. View
5.
Downs S, Thow A, Leeder S . The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence. Bull World Health Organ. 2013; 91(4):262-9H. PMC: 3629452. DOI: 10.2471/BLT.12.111468. View